SCHEMBL30337183

SCHEMBL30337183

Cn1cc(-c2ccnc(Cl)n2)c2cc(I)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.41
GSK3B P49841 5/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
DYRK1B Q9Y463 2/20 0.38
CDK2 P24941 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
EGFR P00533 7/20 0.36
CDK5 Q00535 2/20 0.34
CDK5R1 Q15078 1/20 0.34
AURKA O14965 1/20 0.34
JAK2 O60674 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28987580 1.00 DYRK1A (0.41) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL30459718 0.90 DYRK1A (0.44) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL17683321 0.90 DYRK1A (0.44) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL28987624 0.86 DYRK1A (0.43) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL30337437 0.86 DYRK1A (0.43) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL30337352 0.85 DYRK1A (0.42) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL28987589 0.85 DYRK1A (0.42) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL17490446 0.85 GSK3B (0.54) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL30337440 0.85 GSK3B (0.54) DYRK1AGSK3BCDK1CCNB1DYRK1B
SCHEMBL28987641 0.84 DYRK1A (0.50) DYRK1AGSK3BCDK1CCNB1DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed